Latest Information Update: 20 Jul 2006
At a glance
- Originator Clemson University; Greenville Hospital System
- Class Anterior pituitary hormones; Antineoplastics; Pituitary gonadotropins
- Mechanism of Action Apoptosis stimulants; Prolactin receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Breast cancer